The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease

Acta Neurologica Scandinavica

Volumn 121, Issue 3, 2010, Pages 186-193

  Wiig, E H ^a,g   Annas, P ^b   Basun, H ^b   Andreasen, N ^c   Lannfelt, L ^d   Zetterberg, H ^e   Blennow, K ^e   Minthon, L ^f  

^a BOSTON UNIVERSITY   (United States)

^b ASTRAZENECA R AND D   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f LUND UNIVERSITY   (Sweden)

^g Knowledge Research Institute Inc   (United States)

Author keywords

AchEI treatment; ADAS Cog; Alzheimer's disease; AQT; Longitudinal stability; MMSE; Processing speed

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; P TAU 181 PROTEIN; RIVASTIGMINE; TAU PROTEIN; UNCLASSIFIED DRUG;

A QUICK TEST OF COGNITIVE SPEED; AGED; ALZHEIMER DISEASE; ALZHEIMERS DISEASE ASSESSMENT SCALE COGNITIVE SUBSCALE; ARTICLE; COGNITION; COHORT ANALYSIS; CORRELATION ANALYSIS; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; CHOLINESTERASE INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; PSYCHIATRIC STATUS RATING SCALES; TAU PROTEINS;

EID: 76249087761     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2009.01160.x     Document Type: Article

References (29)

1. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984 141: 1356 1364.
2. Folstein MF, Folstein SE, Mchugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975 12: 189 198.
3. Wiig EH, Nielsen NP, Minthon L, Warkentin S. AQT: A quick test of cognitive speed. San Antonio, TX: Pearson/Psych Corp., 2002.
4. Wiig EH, Nielsen NP, Minthon L, Warkentin S. AQT assessment of parietal function. Norsk-Svensk Versjon. Stockholm, Sweden: Pearson/Psych Corp., 2002.
5. Wiig EH, Nielsen NP, Minthon L, Warkentin S. AQT: A quick test of parietal function. Et kort manual. Norsk-Svensk Versjon. Stockholm, Sweden: Pearson/Psych Corp., 2005.
6. Anderson M, Wiig EH, Londos E, Minthon L. A Quick Test for Cognitive Speed: A measure of cognitive speed in dementia with Lewy bodies. Am J Alzheimer's Dis Demen 2007 22: 313 318.
7. Blennow K, Hampel H. Cerebrospinal fluid markers for incipient Alzheimer's disease. Lancet Neurol 2003 2: 605 613. (Pubitemid 37162569)
8. Blennow K, Zetterberg H, Minthon L et al. Longitudinal stability of CSF biomarkers in Alzheimer's disease. Neurosci Lett 2007 419: 18 22. (Pubitemid 46694097)
9. Algotson A, Winblad B. The integrity of the blood-brain barrier in Alzheimer's disease. Acta Neurol Scand 2007 115: 403 408.
10. Stroop JR. Studies of interference in serial verbal reactions. Psychol Monogr 1935 50: 38 48.
11. Reitan RM, Wolfson D. Category test and trail making test as measures of frontal lobe functions. Clin Neuropsychol 1995 9: 50 6.
12. Jacobson J, Nielsen NP, Minthon L, Warkentin S, Wiig EH. Multiple rapid naming measures of cognition: normal performance and effects of aging. Percept Mot Skills 2004 98: 739 753.
13. Holtzer R, Stern Y, Rakitin BC. Predicting age-related dual-task effects with individual differences on neuropsychological tests. Neuropsychologia 2005 19: 18 27.
14. Wiig EH, Nielsen NP, Jacobson J. A quick test of cognitive speed: patterns of age groups 15 to 95 years. Percept Mot Skills 2007 104: 1067 1075.
15. Vendrell P, Junque C, Pujol J, Jurado MA, Molet J, Grafman J. The role of prefrontal regions in the Stroop task. Neuropsychologia 1995 33: 341 352.
16. Wiig EH, Nielsen NP, Minthon L, Mcpeek D, Said K, Warkentin S. Parietal lobe activation in rapid, automatized naming by adults. Percept Mot Skills 2001 94: 1230 1240.
17. Nielsen NP, Wiig EH, Warkentin S, Minthon L. Clinical utility of color-form naming in Alzheimer's disease: preliminary evidence. Percept Mot Skills 2004 99: 1201 1204.
18. Warkentin S, Tsantali E, Kiosseoglou G et al. The AQT as a useful short screening test for dementia. Evidence from two European cultures. Int Psychogeriatr 2005 17 (Suppl. 2 160.
19. Strauss E, Sherman EMS, Spreen O. A compendium of neuropsychological tests: administration, norms, and commentary. Oxford: Oxford University Press, 2006.
20. Nielsen NP, Ringstrom R, Wiig EH, Minthon L. Associations between AQT processing speed and neuropsychological tests in neuro-psychiatric patients. Am J Alzheimer's Dis Demen 2007 22: 202 210.
21. Wechsler D. Wechsler Adult Intelligence Scale-III. Svensk versjon. Stockholm, Sweden: Pearson/Psych Corp., 2003.
22. Wiig EH, Nielsen NP, Minthon L, Jacobson J. AQT: Efficacy of a new paradigm for cognitive screening. Poster, 2008. 11th International Conference on Alzheimer's Disease, Chicago, IL.
23. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
24. Graham DP, Cully JA, Snow AL, Massman P, Doody R. The Alzheimer's Disease Assessment Scale-Cognitive Subscale: normative data for older adult controls. Alzheimer Dis Assoc Disord 2004 18: 236 240.
25. Clark CM, Sheppard L, Fillenbaum GG et al. Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease. Arch Neurol 1999 56: 857 862.
26. Dufoil C, Clayton D, Brayne C et al. Population norms for the MMSE in the very old: estimates based on longitudinal data. Neurology 2000 55: 1609 1613.
27. Ross-Swain D, Wiig EH. Reductions in RIPA-G information processing and AQT processing speed in Alzheimer's disease: which lead and which follow? Int J Rehab Res 2008 31: 81 4.
28. Tombough TN. Test-retest reliability coefficients and 5-year change scores for the MMSE and 3MS. Arch Clin Neuropsychol 2005 20: 485 503.
29. Doraiswamy PM, Kaiser L, Bieber F, Garman RL. The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease. Alzheimer Dis Assoc Disord 2001 15: 174 183.